Literature DB >> 19095570

Percentage of tumor in prostatectomy specimens: a study of American Veterans.

Robin T Vollmer1.   

Abstract

In this study, I have estimated the percentage of tumor by visual estimate in 447 prostatectomy specimens from American Veterans Affairs patients and related this measurement to overall survival. Although percentage of tumor was significantly related to the serum prostate-specific antigen level, tumor stage, and Gleason score-that is, it was not statistically independent from these-it was more closely associated with overall survival than any of them. Altogether, 2 variables available at the time of the prostatectomy related to survival: patient age (P = .0032; Cox proportional hazards model analysis) and percentage of tumor (P = .0013; Cox model). Patient age undoubtedly reflects the combination of comorbidities and general expected length of life. Percentage of tumor, by contrast, seems to efficiently reflect any undue hazard for early death due to prostate cancer. The results suggest that percentage of tumor is a useful prognostic variable for understanding risk of early death after prostatectomy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19095570     DOI: 10.1309/AJCPX5MAMNMFE6FQ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy.

Authors:  Phillip M Pierorazio; Ashley E Ross; Brian M Lin; Jonathan I Epstein; Misop Han; Patrick C Walsh; Alan W Partin; Christian P Pavlovich; Edward M Schaeffer
Journal:  BJU Int       Date:  2012-02-28       Impact factor: 5.588

2.  The prognostic significance of percentage of tumour involvement according to disease risk group in men treated with radical prostatectomy.

Authors:  Jong Jin Oh; Sang Cheol Lee; Chang Wook Jeong; Cheol Yong Yoon; Seong Jin Jeong; Sung Kyu Hong; Seok-Soo Byun; Yoon Kwan Rho; Gheeyoung Choe; Sang Eun Lee
Journal:  Asian J Androl       Date:  2011-09-26       Impact factor: 3.285

3.  Tumor volume, tumor percentage involvement, or prostate volume: which is predictive of prostate-specific antigen recurrence?

Authors:  Matthew A Uhlman; Leon Sun; Danielle A Stackhouse; Arthur A Caire; Thomas J Polascik; Cary N Robertson; John Madden; Robin Vollmer; David M Albala; Judd W Moul
Journal:  Urology       Date:  2009-10-12       Impact factor: 2.649

4.  Increased cancer-specific mortality of very small size in carcinoembryonic antigen-elevated rectal cancer.

Authors:  Haiqiang Pan; Junhui Cui; Ke Cai; Yena Zhou
Journal:  Ann Transl Med       Date:  2019-09

5.  The tumor volume after radical prostatectomy and its clinical impact on the prognosis of patients with localized prostate cancer.

Authors:  Hyeong Dong Yuk; Seok-Soo Byun; Sung Kyu Hong; Hakmin Lee
Journal:  Sci Rep       Date:  2022-04-09       Impact factor: 4.379

6.  Biochemical recurrence risk factors in surgically treated high and very high-risk prostate tumors.

Authors:  Alfredo Aguilera; Beatriz Bañuelos; Jesús Díez; Jose María Alonso-Dorrego; Jesus Cisneros; Javier Peña
Journal:  Cent European J Urol       Date:  2015-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.